Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid

Breast cancer is the leading cause of cancer-related death in women. Among breast cancer types, triple-negative breast cancer (TNBC) accounts for 15% of all breast cancers with aggressive tumor behavior. By using bioinformatic approaches, we observed that the microRNA-708 promoter is highly methylat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Yu-Hsin, Huang, Yi-Chen, Chiu, Pei-Yun, Kuo, Wen-Hung, Pan, Yan-Ru, Kuo, Yuan-Ting, Wang, Rong-Hsuan, Kao, Yu-Chin, Wang, Yi-Hsiang, Lin, Yi-Fan, Lin, Kai-Ti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148121/
https://www.ncbi.nlm.nih.gov/pubmed/37128608
http://dx.doi.org/10.1016/j.isci.2023.106597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148121/
https://www.ncbi.nlm.nih.gov/pubmed/37128608
http://dx.doi.org/10.1016/j.isci.2023.106597

Ejemplares similares